A Gain-of-Function Mutation in KCNMA1 Causes Dystonia Spells Controlled With Stimulant Therapy.

A Gain-of-Function Mutation in KCNMA1 Causes Dystonia Spells Controlled With Stimulant Therapy.
复制标题

DOI:
10.1002/mds.28138
复制
发表时间:
2020-10
期刊:
Movement disorders : official journal of the Movement Disorder Society
影响因子:
--
通讯作者:
Mikati MA
Mikati MA
中科院分区:
其他
文献类型:
--
作者:
Zhang G;Gibson RA;McDonald M;Liang P;Kang PW;Shi J;Yang H;Cui J;Mikati MA

文献摘要

参考文献

被引文献

相似文献

KCNMA1 BK型K+通道突变在各种运动障碍患者中已被发现。缺乏潜在的病理生理学和相应的治疗方法。报告我们的临床和生物物理特征,一种新的从头开始的KCNMA1变体,以及一种治疗患者肌张力障碍的有效方法。患者及其突变的表型特征、治疗和生物物理特征的组合。患者每天有100多次肌张力障碍-张力障碍发作,并伴有轻度小脑萎缩。她还患有自闭症谱系障碍、智力残疾和注意力缺陷多动障碍。外显子全序列测定发现BKN536H杂合子突变。我们的生物物理特征表明,N536H是一个功能增益(GOF)突变,具有显著增强的电压依赖激活。值得注意的是,注射右旋安非他明完全抑制了肌张力障碍。BK N536H是一种导致肌张力障碍和其他神经症状的GOF。我们的刺激疗法为缓解KCNMA1相关的运动障碍开辟了一条新的途径。
The mutations of KCNMA1 BK type K+ channel have been identified in patients with various movement disorders. The underlying pathophysiology and corresponding therapeutics are lacking. To report our clinical and biophysical characterizations a novel de novo KCNMA1 variant, as well as an effective therapy for the patient’s dystonia-atonia spells. Combination of phenotypic characterization, therapy and biophysical characterization of the patient and her mutation. The patient had more than one hundred dystonia-atonia spells per day with mild cerebellar atrophy. She also had autism spectrum disorder, intellectual disability, and attention deficit hyperactivity disorder. Whole exome sequencing identified a heterozygous de novo BK N536H mutation. Our biophysical characterization demonstrates that N536H is a gain-of-function (GOF) mutation with markedly enhanced voltage dependent activation. Remarkably, administration of dextroamphetamine completely suppressed the dystonia-atonia spells. BK N536H is a GOF that causes dystonia and other neurological symptoms. Our stimulant therapy opens a new avenue to mitigate KCNMA1-linked movement disorders.
DOI: 10.1152/jn.00461.2006
发表时间: 2006-09-01
影响因子: 2.5
作者:
Diez-Sampedro, Ana;Silverman, William R.;Richerson, George B.
通讯作者: Richerson, George B.
DOI: 10.1523/jneurosci.1392-16.2016
发表时间: 2016-10-05
影响因子: 5.3
作者:
Lin, Min;Sambo, Danielle;Khoshbouei, Habibeh
通讯作者: Khoshbouei, Habibeh
DOI: 10.4274/balkanmedj.2017.0986
发表时间: 2018-07-24
影响因子: 3
作者:
Yeşil G;Aralaşmak A;Akyüz E;İçağasıoğlu D;Uygur Şahin T;Bayram Y
通讯作者: Bayram Y
DOI: 10.1038/ng1585
发表时间: 2005-07-01
期刊: NATURE GENETICS
影响因子: 30.8
作者:
Du, W;Bautista, JF;Wang, QK
通讯作者: Wang, QK
DOI: 10.1152/jn.00626.2019
发表时间: 2020-02-01
影响因子: 2.5
作者:
Moldenhauer, Hans J.;Matychak, Katia K.;Meredith, Andrea L.
通讯作者: Meredith, Andrea L.